HDO-antimiR represents a new weapon in the fight against microRNA-related disease

HDO-antimiR represents a new weapon in the fight against microRNA-related disease
Researchers from Tokyo Medical and Dental University (TMDU) develop a new form of a molecule that can inhibit microRNA, which is implicated in various genetic diseases, uncovering a new treatment approach. Credit: TMDU

MicroRNA (miRNA) is a type of RNA that plays an important role in various cellular processes and is also involved in developing defenses against pathogens. Increasing numbers of studies have indicated that certain human diseases are caused by altered expression and organization of miRNA.

Kotaro Yoshioka and Takanori Yokota of Tokyo Medical and Dental University (TMDU) have developed new that can silence or inhibit malfunctioning miRNA, with the hope that their work could lead to new ways to treat diseases which are caused by the miRNAs. Creating a new type of antimiR, which is a molecule that inhibits miRNA, could provide the foundation for new gene therapies.

Yoshioka and Yokota recently developed a new type of antimiR with heightened efficacy against miRNA and lowered toxicity, using their original technique, hetero duplex oligonucleotides (HDO). They combined an antimiR with its complementary RNA to produce a new molecule, termed "HDO-antimiR". They then characterized HDO-antimiR—specifically, they evaluated its strength in inhibiting miRNA, assessed its biological distribution, and checked its specific action by modifying its structure in mice. They recently published their findings in Nucleic Acids Research.

"HDO-antimiR has a unique double-strand structure that is totally different from previously described antimiRs," corresponding author Yokota says. "This structure is responsible for a substantial increase in the potency of miRNA silenced by HDO-antimiR compared with the single-stranded parent antimiR."

HDO-antimiR represents a new weapon in the fight against microRNA-related disease
This image illustrates the molecular mechanism how double-stranded HDO-antimiR silences the targeted microRNA within cells in comparison with the original single-stranded antimiR. Credit: TMDU

The researchers found that compared with conventional antimiR, HDO-antimiR was 12 times as efficient in terms of binding to targeted miRNA, and had improved potency within cells. Further, HDO-antimiR produced enhanced phenotypic effects in mice, specifically increasing the expression of mRNA that targets miRNA, leading to greater miRNA inhibition.

The heightened potency of HDO-antimiR was not related to high bio-stability or an increased rate of delivery to the targeted cell. Although these are common explanations for increased potency, in this case it was a reflection of improved strength once the molecule had entered the cells. This indicates that the unique structure of HDO-antimiR enabled it to behave differently than other types of miRNA inhibitors.

Explore further

New insight into the maturation of miRNAs

More information: Kotaro Yoshioka et al, Highly efficient silencing of microRNA by heteroduplex oligonucleotides, Nucleic Acids Research (2019). DOI: 10.1093/nar/gkz492
Journal information: Nucleic Acids Research

Provided by Tokyo Medical and Dental University
Citation: HDO-antimiR represents a new weapon in the fight against microRNA-related disease (2019, July 26) retrieved 20 January 2021 from https://phys.org/news/2019-07-hdo-antimir-weapon-microrna-related-disease.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments